Atossa Therapeutics (ATOS) Earnings Date & Reports

Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

ATOS is expected to report earnings to rise 9.47% to -103 cents per share on November 16

Atossa Therapeutics ATOS Stock Earnings Reports

Q3'26

Est.

$-1.04

Q2'26

Beat

by $0.10

Q1'26

Missed

by $1.04

Q4'25

Missed

by $1.20

Q3'25

Missed

by $0.01

The last earnings report on August 07 showed earnings per share of -94 cents, beating the estimate of -104 cents. With 51.79K shares outstanding, the current market capitalization sits at 19.56M.

View a ticker or compare two or three

ATOS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ATOS